Related Experiment Videos

Sulfated glucuronyl paragloboside in rat brain microvessels

N Miyatani1, T Kohriyama, Y Maeda

  • 1Department of Biochemistry and Molecular Biophysics, Medical College of Virginia, Richmond 23298-0614.

Insights

Monoclonal antibodies in paraproteinemic neuropathy may target brain endothelial cells. This interaction could breach the blood-brain barrier, allowing immunoglobulin entry and nerve damage.

Area of Science:

  • Neuroimmunology
  • Vascular Biology
  • Glycosphingolipid Biochemistry

Background:

  • Neuropathy associated with paraproteinemia involves monoclonal IgM antibodies targeting myelin-associated glycoprotein and sulfated glucuronyl glycolipids.
  • The mechanism of autoantibody access to nervous tissue across the blood-brain barrier (BBB) or blood-nerve barrier (BNB) remains unclear.

Purpose of the Study:

  • To investigate the presence of sulfated glucuronyl glycolipid antigens on brain endothelial cells.
  • To explore a potential mechanism for autoantibody penetration into the central nervous system.

Main Methods:

  • Isolation of microvessels from adult Lewis rat brain cortex.
  • Detection of sulfated glucuronyl paragloboside (SGPG) using thin-layer chromatography (TLC) immunostaining.
  • Immunofluorescence studies on microvessels and cultured human umbilical vein endothelial cells.

Main Results:

  • SGPG was identified in the acidic lipid fraction of rat brain microvessels.
  • Positive immunofluorescence staining for SGPG was observed on the surface of isolated microvessels.
  • SGPG was also detected in cultured human umbilical vein endothelial cells.

Conclusions:

  • Endothelial cells possess antigenic sites (SGPG) capable of interacting with autoantibodies.
  • This interaction may impair endothelial cell function, altering BBB permeability.
  • Increased BBB permeability could facilitate immunoglobulin entry into the endoneurial space, contributing to neuropathy.

Related Concept Videos